| __timestamp | Amneal Pharmaceuticals, Inc. | MiMedx Group, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 785623000 | 118223000 |
| Thursday, January 1, 2015 | 866280000 | 187296000 |
| Friday, January 1, 2016 | 1018225000 | 245015000 |
| Sunday, January 1, 2017 | 1033654000 | 321139000 |
| Monday, January 1, 2018 | 1662991000 | 359111000 |
| Tuesday, January 1, 2019 | 1626373000 | 299255000 |
| Wednesday, January 1, 2020 | 1992523000 | 248234000 |
| Friday, January 1, 2021 | 2093669000 | 258615000 |
| Saturday, January 1, 2022 | 2212304000 | 267841000 |
| Sunday, January 1, 2023 | 2393607000 | 321477000 |
Infusing magic into the data realm
In the competitive landscape of the pharmaceutical industry, revenue growth is a key indicator of success. Over the past decade, Amneal Pharmaceuticals, Inc. has demonstrated a robust upward trajectory, with its revenue increasing by approximately 205% from 2014 to 2023. This growth reflects Amneal's strategic expansions and market adaptability. In contrast, MiMedx Group, Inc. has experienced a more modest revenue increase of around 172% during the same period. Despite facing challenges, MiMedx has shown resilience, particularly in the regenerative medicine sector.
The data reveals that Amneal's revenue consistently outpaced MiMedx's, with a notable surge in 2023, reaching nearly 2.4 billion USD. Meanwhile, MiMedx's revenue peaked at around 321 million USD. These insights highlight the dynamic nature of the pharmaceutical market and the varying strategies companies employ to achieve growth.
Revenue Insights: Johnson & Johnson and Amneal Pharmaceuticals, Inc. Performance Compared
Annual Revenue Comparison: Merck & Co., Inc. vs Amneal Pharmaceuticals, Inc.
Revenue Insights: Sanofi and Amneal Pharmaceuticals, Inc. Performance Compared
Who Generates More Revenue? Takeda Pharmaceutical Company Limited or Amneal Pharmaceuticals, Inc.
Revenue Insights: Bio-Techne Corporation and Amneal Pharmaceuticals, Inc. Performance Compared
Bio-Techne Corporation and MiMedx Group, Inc.: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Halozyme Therapeutics, Inc. vs MiMedx Group, Inc.
Breaking Down Revenue Trends: Ionis Pharmaceuticals, Inc. vs MiMedx Group, Inc.
Who Generates More Revenue? Amneal Pharmaceuticals, Inc. or ImmunityBio, Inc.
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and MiMedx Group, Inc.
Celldex Therapeutics, Inc. vs MiMedx Group, Inc.: Annual Revenue Growth Compared
Comparing Revenue Performance: Xencor, Inc. or MiMedx Group, Inc.?